However, we did observe that low-dose 2-DG and metformin given in combination significantly increased the radiosensitivity of UVW/NAT cells but had negligible effects on SK-N-BE(2c) neuroblastoma cells, even when treatment was extended to 48 h. The gene discussed is BRD2; the disease is neuroblastoma.